Schrodinger (NASDAQ:SDGR) versus Zhongchao (NASDAQ:ZCMD) Head-To-Head Survey

Zhongchao (NASDAQ:ZCMD) and Schrodinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk.

Profitability

This table compares Zhongchao and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Schrodinger	-68.49%	-48.24%	-24.21%

Analyst Recommendations

This is a breakdown of current ratings and target prices for Zhongchao and Schrodinger, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1	0	0	0	1.00
Schrodinger	1	4	6	0	2.45

Schrodinger has a consensus target price of $24.33, indicating a potential upside of 32.90%. Given Schrodinger’s stronger consensus rating and higher possible upside, analysts plainly believe Schrodinger is more favorable than Zhongchao.

Earnings and Valuation

This table compares Zhongchao and Schrodinger”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$15.86 million	0.91	-$640,000.00	N/A	N/A
Schrodinger	$207.54 million	6.50	-$187.12 million	($2.41)	-7.60

Zhongchao has higher earnings, but lower revenue than Schrodinger.

Institutional and Insider Ownership

1.7% of Zhongchao shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 28.6% of Zhongchao shares are held by company insiders. Comparatively, 21.0% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Risk & Volatility

Zhongchao has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.

Summary

Schrodinger beats Zhongchao on 7 of the 12 factors compared between the two stocks.

About Zhongchao

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.